General Information of the Compound
Compound ID |
CP0496194
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(1-((1R,4R)-2,2-dimethyl-4-((R)-1-phenylethylamino)cyclohexanecarbonyl)-4-phenylpiperidin-4-yl)(pyrrolidin-1-yl)methanone
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C33H45N3O2
|
||||||||||||||||||
Molecular Weight |
515.742
|
||||||||||||||||||
Canonical SMILES |
C[C@@H](N[C@@H]1CC[C@@H](C(=O)N2CCC(CC2)(C(=O)N2CCCC2)c2ccccc2)C(C)(C)C1)c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C33H45N3O2/c1-25(26-12-6-4-7-13-26)34-28-16-17-29(32(2,3)24-28)30(37)35-22-18-33(19-23-35,27-14-8-5-9-15-27)31(38)36-20-10-11-21-36/h4-9,12-15,25,28-29,34H,10-11,16-24H2,1-3H3/t25-,28-,29+/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
FYJDUABSMKOHTB-ZJGIAAPESA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02259, Neuropeptide Y receptor type 1
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2